Indolylalkylamine metabolites as 5-hydroxytryptamine-6 ligands
US7498327B2 · kind B2 · utility
1Cited by
5References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 22, 2005 |
| Grant date | Mar 3, 2009 |
| Priority date | — |
| Expiry date | Nov 25, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H15/26
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.